The Front Room — a clinical regulatory commons
RSS
← Back to feed

RHA Redensity Eye cleared for undereye hollows

Sponsor
Revance
Drug
RHA Redensity Eye · hyaluronic acid filler
Indication
Correction of moderate to severe tissue volume deficiencies in the infraorbital region (undereye hollows)
More on Revance ↗ Google News

FDA approves RHA Redensity Eye hyaluronic acid filler for correction of moderate to severe tissue volume deficiencies in the infraorbital region.

What this means

RHA Redensity Eye is a hyaluronic acid filler used to add volume and smooth the appearance of undereye hollows. The FDA cleared this specific product for correcting moderate to severe undereye volume loss. This provides clinicians and patients with a new, formally evaluated option for this delicate facial area.

Read original at prnewswire.com ↗
Topic Dermal filler approval